Tcf-3 and β-catenin in Aggressive Fibromatosis
Author Information
Author(s): Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R, Cutsem E Van, Cassiman J J, Alman B A
Primary Institution: The Program in Developmental Biology, The Hospital for Sick Children and the University of Toronto
Hypothesis
Aggressive fibromatosis harbours mutations resulting in β-catenin protein stabilization.
Conclusion
The study demonstrates that β-catenin binds and activates tcf-3 in aggressive fibromatosis, marking the first evidence of this activation in a human tumor.
Supporting Evidence
- Mutations in aggressive fibromatosis lead to β-catenin protein stabilization.
- Primary cell cultures show constitutive tcf activation in aggressive fibromatosis.
- β-catenin binds and activates tcf-3 in this tumor.
Takeaway
This study found that a protein called β-catenin helps activate another protein, tcf-3, in a type of tumor called aggressive fibromatosis.
Methodology
Primary cell cultures and co-immunoprecipitation studies were used to investigate the relationship between β-catenin and tcf-3.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website